E
Ocean Biomedical, Inc. OCEA
$0.04 -$0.0015-3.61% NASDAQ
Recommendation
Prev Close
$0.0415
Volume
4,896,940
Avg Vol (90D)
38,347,494
Market Cap
$6.89M
Dividend & Yield
--
52-Week Range
$0.037 - $2.09
P/E (TTM)
--
EPS (TTM)
-$0.3425
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Troubled Brown spinoff Ocean Biomedical racked up more losses in 2024
4/14/2025 - Bizjournals.com - Health Care News
Ocean Biomedical Delays Yearly Report Filing
4/1/2025 - TipRanks Financial Blog
Ocean Biomedical granted notice of grant on patent right by CNIPA
3/28/2025 - The Fly
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
3/28/2025 - Globe Newswire
Four board members to exit troubled RI biotech
3/27/2025 - BizJournals.com - Nat'l Business News
Ocean Biomedical announces findings in EGFR-mutant lung cancer
2/10/2025 - The Fly
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA ...
2/10/2025 - GuruFocus
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
2/10/2025 - Globe Newswire
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited ...
1/29/2025 - GuruFocus
Ocean Biomedical advances malaria vaccine research with new funding, pathway
1/29/2025 - The Fly
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
1/29/2025 - Globe Newswire
Cameron and Mittleman wants to cut ties with Ocean Biomedical
1/14/2025 - Bizjournals.com - Health Care News
Zero revenue, multiple lawsuits: Brown spinoff Ocean Biomedical caught in maelstrom
1/9/2025 - Banking News-Bizjournals.com
Ocean Biomedical faces Nasdaq delisting hearing
11/25/2024 - Bizjournals.com - Health Care News
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of ...
11/22/2024 - GuruFocus
Ocean Biomedical Faces Nasdaq Delisting Threat
11/22/2024 - TipRanks Financial Blog
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of ...
11/22/2024 - GuruFocus
Ocean Biomedical receives notice from Nasdaq regarding late filing
11/22/2024 - SeekingAlpha.com: All News
Ocean Biomedical receives notice from Nasdaq regarding late filing
11/22/2024 - Seeking Alpha - Healthcare
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
11/22/2024 - Globe Newswire
Ocean Biomedical receives Nasdaq's delisting letter
10/22/2024 - Seeking Alpha - Healthcare
Ocean Biomedical receives noncompliance letter from Nasdaq
10/22/2024 - The Fly
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter
10/22/2024 - Globe Newswire
Ocean Biomedical signs $32M pact with Polish biotech for preclinical YKL-40 inhibitors
10/15/2024 - FierceBiotech.com - Biotech
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$3.80M
Net Income (TTM)
-$9.48M
Balance Sheet
Total Assets (Q)
$902.00K
Total Debt (Q)
$22.47M
Total Liabilities (Q)
$98.52M
Book Value Per Share (Q)
-$2.80
Cash Flow
Cash from Operations (TTM)
-$4.18M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$3.40M
Net Change in Cash (TTM)
-$780.00K
Filings
Filing Date
Tuesday, April 8, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Nov 24 and 28 (est)
Price History
Loading...
Beta
2.31
7-Day Total Return
-14.89%
30-Day Total Return
-55.56%
60-Day Total Return
-91.11%
90-Day Total Return
-94.24%
Year to Date Total Return
-93.28%
1-Year Total Return
-97.87%
2-Year Total Return
-99.41%
3-Year Total Return
-99.60%
5-Year Total Return
--
52-week Low
Apr 17, 2025 - $0.037
52-week High
May 09, 2024 - $2.09
Valuation
Market Cap
$6.89M - Nano Cap
Enterprise Value
$29.36M
Price/Sales (TTM)
--
Price/Book (Q)
-0.01
Dividends and Shares
Shares Outstanding
27.67M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.oceanbiomedical.com
Phone Number
401 444 7375
Address
55 Claverick Street
Providence, RI 02903
Country
United States
Year Founded
2019
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company... more
NASDAQ 04/21/2025 4:00PM Eastern Quotes delayed